個人投資家向けオンライン会社説明会 大同薬品工業の成長に向けた取り組み

This document is related to the online company briefing held for individual investors on October 18, 2022, focusing on the growth strategies and business overview of Daido Pharmaceutical Industry. As part of DyDo Group Holdings, it discusses the outlook for pharmaceutical and beverage businesses, particularly the contract manufacturing business model and new partnerships. The document emphasizes the group's mission towards 2030 and its efforts to achieve a sustainable society, providing valuable information to investors.